Manifold Bio
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
- Location
- Boston, United States, United States
- Founded
- 2020
- Category
- SaaS
- Funding
- VC-backed
- Team
- 11–50
Frequently asked questions
What does Manifold Bio do?
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Where is Manifold Bio based?
Manifold Bio is based in Boston, United States, United States.
When was Manifold Bio founded?
Manifold Bio was founded in 2020.
How much has Manifold Bio raised?
Manifold Bio is vc-backed. Funding details have not been disclosed.
How Manifold Bio would pitch themselves
○ Auto-generated01Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
02Problem they solve
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered de… The category has historically been served by tools that miss the modern workflow this product is built around.
03Key differentiator
Manifold Bio differentiates on tissue-targeted medicines, designed in vivo — focusing on a specific edge in this category vs. broader incumbents.
04Go-to-market strategy
Series-A scaling stage — building outbound sales motion, hiring first AEs, layering on customer success. Mix of PLG (where the product allows) + direct sales for higher-ACV deals.